Cargando…
Structural and phylogenetic analyses of resistance to next-generation aminoglycosides conferred by AAC(2′) enzymes
Plazomicin is currently the only next-generation aminoglycoside approved for clinical use that has the potential of evading the effects of widespread enzymatic resistance factors. However, plazomicin is still susceptible to the action of the resistance enzyme AAC(2′)-Ia from Providencia stuartii. As...
Autores principales: | Bassenden, Angelia V., Dumalo, Linda, Park, Jaeok, Blanchet, Jonathan, Maiti, Krishnagopal, Arya, Dev P., Berghuis, Albert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172861/ https://www.ncbi.nlm.nih.gov/pubmed/34078922 http://dx.doi.org/10.1038/s41598-021-89446-3 |
Ejemplares similares
-
Structural basis for plazomicin antibiotic action and resistance
por: Golkar, Tolou, et al.
Publicado: (2021) -
Structural elucidation of substrate-bound aminoglycoside acetyltransferase (3)-IIIa
por: Zieliński, Michał, et al.
Publicado: (2022) -
Aminoglycoside resistance profile and structural architecture of the aminoglycoside acetyltransferase AAC(6')-Im
por: Smith, Clyde A., et al.
Publicado: (2017) -
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
por: Ramirez, María S., et al.
Publicado: (2013) -
The prevalence of aminoglycoside-modifying enzyme genes (aac (6′)-I, aac (6′)-II, ant (2″)-I, aph (3′)-VI) in Pseudomonas aeruginosa
por: Vaziri, Farzam, et al.
Publicado: (2011)